Directors

Rajesh Gupta Kumar

Director/Designated Partner
over 24 years ago

Meenakshi Gupta

Director/Designated Partner
about 25 years ago

Past Directors

Patents

Compositions And Methods Of Treating Retinal Disease

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Documents

Form MGT-7-11112019_signed

Form AOC-4-10112019_signed

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-05112019

Directors report as per section 134(3)-05112019

List of share holders, debenture holders;-05112019

Form DPT-3-27062019

Form AOC-4-27112018_signed

Form MGT-7-27112018_signed

List of share holders, debenture holders;-23112018

Directors report as per section 134(3)-22112018

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22112018

Directors report as per section 134(3)-14112017

List of share holders, debenture holders;-14112017

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-14112017

Form MGT-7-14112017_signed

Form AOC-4-14112017_signed

Optional Attachment-(1)-04102016

Directors report as per section 134(3)-04102016

List of share holders, debenture holders;-04102016

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-04102016

Form AOC-4-04102016

Form MGT-7-04102016_signed

Form DIR-12-14072016_signed

Acknowledgement received from company-14072016

Notice of resignation;-14072016

Proof of dispatch-14072016

Notice of resignation filed with the company-14072016

Form DIR-11-14072016_signed

Evidence of cessation;-14072016

Company Information